T1	Drug 22 46	anti-diabetic medication
T2	Temporal 0 8	Previous
T3	Procedure 9 16	treated
R1	AND Arg1:T3 Arg2:T1	
R2	Has_temporal Arg1:T3 Arg2:T2	
T4	Condition 48 56	Pregnant
T5	Condition 60 67	nursing
T6	Person 68 73	women
*	OR T5 T4
T7	Condition 76 99	Impaired liver function
T8	Measurement 101 104	ALT
T9	Value 105 114	> 120 U/L
R3	Has_value Arg1:T8 Arg2:T9	
T10	Scope 101 114	ALT > 120 U/L
R4	Subsumes Arg1:T7 Arg2:T10	
T11	Condition 117 140	Impaired renal function
T12	Measurement 142 158	Serum creatinine
T13	Value 159 169	>1.5 mg/dL
T14	Person 173 177	male
T15	Person 193 199	female
T16	Value 179 189	>1.4 mg/dL
A1	Optional T14
A2	Optional T15
R5	Has_value Arg1:T14 Arg2:T13	
R6	Has_value Arg1:T15 Arg2:T16	
*	OR T14 T15
T17	Scope 159 199	>1.5 mg/dL in male, >1.4 mg/dL in female
R7	Has_scope Arg1:T12 Arg2:T17	
R8	AND Arg1:T11 Arg2:T12	
T18	Condition 226 228	MI
T19	Condition 232 235	CVA
T20	Temporal 203 211	Recently
*	OR T18 T19
T21	Scope 226 235	MI or CVA
R9	Has_temporal Arg1:T21 Arg2:T20	
T22	Condition 251 277	acute intercurrent illness
T23	Measurement 280 302	2-hour C-peptide level
T24	Value 303 314	< 1.8 ng/mL
R10	Has_value Arg1:T23 Arg2:T24	
